221 related articles for article (PubMed ID: 24889123)
1. Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
Fei C; Zhao Y; Guo J; Gu S; Li X; Chang C
Eur J Haematol; 2014 Dec; 93(6):476-86. PubMed ID: 24889123
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.
Zhao Y; Wu D; Fei C; Guo J; Gu S; Zhu Y; Xu F; Zhang Z; Wu L; Li X; Chang C
Haematologica; 2015 Feb; 100(2):194-204. PubMed ID: 25361944
[TBL] [Abstract][Full Text] [Related]
3. Notch-Hes pathway mediates the impaired osteogenic differentiation of bone marrow mesenchymal stromal cells from myelodysplastic syndromes patients through the down-regulation of Runx2.
Fei C; Guo J; Zhao Y; Gu S; Zhao S; Li X; Chang C
Am J Transl Res; 2015; 7(10):1939-51. PubMed ID: 26692937
[TBL] [Abstract][Full Text] [Related]
4. miR-29c-3p promotes senescence of human mesenchymal stem cells by targeting CNOT6 through p53-p21 and p16-pRB pathways.
Shang J; Yao Y; Fan X; Shangguan L; Li J; Liu H; Zhou Y
Biochim Biophys Acta; 2016 Apr; 1863(4):520-32. PubMed ID: 26792405
[TBL] [Abstract][Full Text] [Related]
5. Cellular senescence induced by S100A9 in mesenchymal stromal cells through NLRP3 inflammasome activation.
Shi L; Zhao Y; Fei C; Guo J; Jia Y; Wu D; Wu L; Chang C
Aging (Albany NY); 2019 Nov; 11(21):9626-9642. PubMed ID: 31727865
[TBL] [Abstract][Full Text] [Related]
6. p53/p21 Pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
Gu Z; Jiang J; Tan W; Xia Y; Cao H; Meng Y; Da Z; Liu H; Cheng C
Clin Dev Immunol; 2013; 2013():134243. PubMed ID: 24151513
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p53-p21 pathway promotes the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes.
Yan X; Lv A; Xing Y; Liu B; Hou J; Huang W; Li Y
Mol Cell Biochem; 2011 Aug; 354(1-2):21-8. PubMed ID: 21468649
[TBL] [Abstract][Full Text] [Related]
8. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
10. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
[TBL] [Abstract][Full Text] [Related]
11. Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts.
Cheng H; Qiu L; Ma J; Zhang H; Cheng M; Li W; Zhao X; Liu K
Mol Biol Rep; 2011 Nov; 38(8):5161-8. PubMed ID: 21188535
[TBL] [Abstract][Full Text] [Related]
12. CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence.
Xiao Y; Wang J; Song H; Zou P; Zhou D; Liu L
Leuk Res; 2013 Mar; 37(3):333-40. PubMed ID: 23219618
[TBL] [Abstract][Full Text] [Related]
13. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.
Geyh S; Oz S; Cadeddu RP; Fröbel J; Brückner B; Kündgen A; Fenk R; Bruns I; Zilkens C; Hermsen D; Gattermann N; Kobbe G; Germing U; Lyko F; Haas R; Schroeder T
Leukemia; 2013 Sep; 27(9):1841-51. PubMed ID: 23797473
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway.
Gu Z; Tan W; Feng G; Meng Y; Shen B; Liu H; Cheng C
Mol Cell Biochem; 2014 Feb; 387(1-2):27-37. PubMed ID: 24130040
[TBL] [Abstract][Full Text] [Related]
15. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
[TBL] [Abstract][Full Text] [Related]
16. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
17. A Senescence-Associated Secretory Phenotype of Bone Marrow Mesenchymal Stem Cells Inhibits the Viability of Breast Cancer Cells.
Li M; Liu JX; Ma B; Liu JY; Chen J; Jin F; Hu CH; Xu HK; Zheng CX; Hou R
Stem Cell Rev Rep; 2024 May; 20(4):1093-1105. PubMed ID: 38457059
[TBL] [Abstract][Full Text] [Related]
18. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
Mattiucci D; Maurizi G; Leoni P; Poloni A
Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen alleviates cellular senescence via regulation of ROS/p53/p21 pathway in bone marrow-derived mesenchymal stem cells in vivo.
Zhang W; Huang C; Sun A; Qiao L; Zhang X; Huang J; Sun X; Yang X; Sun S
Biomed Pharmacother; 2018 Oct; 106():1126-1134. PubMed ID: 30119179
[TBL] [Abstract][Full Text] [Related]
20. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
